Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/27/2005CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/2005CA2139670C Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
09/27/2005CA2108104C Fibrin sealant compositions and methods for utilizing same
09/27/2005CA2099612C Monokine mig induced by ifn-gamma
09/22/2005WO2005087931A1 Modified oncolytic viruses
09/22/2005WO2005087930A1 Polynucleotides for the detection of escherichia coli o157
09/22/2005WO2005087929A1 Infectious aetiology of prostatic disease and methods to identify causative agents
09/22/2005WO2005087928A1 Proteins imparting boron-tolerance and genes thereof
09/22/2005WO2005087927A1 Method for preparation and purification or recombinant proteins
09/22/2005WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance
09/22/2005WO2005087813A1 Chimeric antigens comprising an fc-fragment for eliciting an immune response
09/22/2005WO2005087810A2 Dimeric fusion proteins and materials and methods for producing them
09/22/2005WO2005087809A2 Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion
09/22/2005WO2005087808A2 Growth factor binding constructs materials and methods
09/22/2005WO2005087807A1 Vr1 receptors and uses thereof
09/22/2005WO2005087806A2 Cd38 splice variant and uses thereof
09/22/2005WO2005087805A1 Treating or preventing extracellular matrix build-up
09/22/2005WO2005087804A1 Erythropoietin liquid formulation
09/22/2005WO2005087803A1 A canine vaccine for protection against ehrlichiosis
09/22/2005WO2005087802A2 Process for producing polypeptides
09/22/2005WO2005087801A1 Peptide carrier for drug delivery
09/22/2005WO2005087800A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
09/22/2005WO2005087799A2 Mvl, an antiviral protein from a cyanobacterium
09/22/2005WO2005087797A1 Methods and compositions for the treatment of gastrointestinal disorders
09/22/2005WO2005087793A2 Immunostimulatory compositions and uses thereof
09/22/2005WO2005087263A1 Vaccine for preventing and/or treating a herpes virus infection
09/22/2005WO2005087261A2 Identification of self and non-self antigens implicated in autoimmune diseases
09/22/2005WO2005087250A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y
09/22/2005WO2005087249A1 Protease inhibitor and preventives or remedies for diseases
09/22/2005WO2005086967A2 Therapeutic use of rm1 antigen
09/22/2005WO2005086947A2 Method for inhibiting immune complex formation in a subjetc
09/22/2005WO2005086922A2 Oncolytic adenovirus armed with therapeutic genes
09/22/2005WO2005086813A2 Glutamine-rich maize seed protein and promoter
09/22/2005WO2005086800A2 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
09/22/2005WO2005086798A2 Improved interleukin-2 muteins
09/22/2005WO2005086794A2 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
09/22/2005WO2005086751A2 Combinatorial interleukin-2 muteins
09/22/2005WO2005086695A2 Intracellular interleukin-1 receptor antagonist and uses thereof
09/22/2005WO2005086674A2 Brhf1 as a cancer diagnostic marker
09/22/2005WO2005086667A2 High efficiency peptide production in plant cells
09/22/2005WO2005086663A2 Polypeptides for inducing a protective immune response against staphlococcus aureus
09/22/2005WO2005086611A2 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions
09/22/2005WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
09/22/2005WO2005080418A3 Multimerised hiv fusion inhibitors
09/22/2005WO2005073384A3 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
09/22/2005WO2005070214A8 Peptides for inhibiting insects
09/22/2005WO2005069913A3 Expression of mammalian proteins in pseudomonas fluorescens
09/22/2005WO2005068498A3 Human therapeutic cells secreting nerve growth factor
09/22/2005WO2005058946A3 Methods for enhancing expression of recombinant proteins
09/22/2005WO2005049072A3 Therapeutic cancer vaccine with fragments of trag-3
09/22/2005WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof
09/22/2005WO2005034844A3 Exosite-directed thrombin inhibitors
09/22/2005WO2005031362A3 Novel antibacterial agents and methods of identifying and utilizing same
09/22/2005WO2005014825A3 Methods of protein production in yeast
09/22/2005WO2005014624A3 Preparation of somatostatin peptides
09/22/2005WO2004104174A3 Polyubiquitin rubi3 promoter and 5' regulatory sequences
09/22/2005WO2004101606A3 Novel peptides that bind to the erythropoietin receptor
09/22/2005WO2004096848A8 Novel composition and methods for the treatment of immune disorders
09/22/2005WO2004094671A3 Methods and products for identification and assessment of tlr ligands
09/22/2005WO2004007669A3 Protein chips
09/22/2005WO2003065997A3 Anti-infarction molecules
09/22/2005WO2003062374A3 Synthetic genes for malarial proteins and methods of use
09/22/2005WO2003025137A3 Sweet taste receptors
09/22/2005WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof
09/22/2005US20050210547 Plant control genes
09/22/2005US20050210546 Generation of plants with improved pathogen resistance
09/22/2005US20050210545 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in transformation and propagation of insect resistant crop plants; biological pest control
09/22/2005US20050210544 Using vector transformation of nucleotide sequences coding S-phase specific ribosomal protein (S3A) as tool in enhancing propagation of crop plants
09/22/2005US20050210543 Expression vector comprising nucleotide sequences coding restriction enzyme for use as tool in generation of insertional mutations among related polynucleotides, via vitro heteroduplex molecule formation
09/22/2005US20050210540 Expression vector comprising nucleotide sequence coding glycine transport protein for use in generating animal models which identify modulators of psychotic behavior
09/22/2005US20050210539 Methods of preforming homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
09/22/2005US20050210538 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders
09/22/2005US20050210536 Using vector transformation to brain disorder animal model for use in identifying modulators for treatment and prevention of nervous system, brain and psychological disorders
09/22/2005US20050210535 Parasite integral membrane protein for use as tool in identifying modulators and devlopment of vaccines for prevention and treatment of toxoplasmosis
09/22/2005US20050209448 Secretion, transcription and sporulation genes in bacillus clauslii
09/22/2005US20050209443 Flavor active modified thaumatin and monellin and methods for their production and use
09/22/2005US20050209441 Using human serum albumin refolding ligand as tool in reanaturation of recombinant serum proteins
09/22/2005US20050209178 Methods and compositions for the treatment of obesity
09/22/2005US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction
09/22/2005US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor
09/22/2005US20050209158 Inhibitors of the ATPase activity of Hsp90; antitumor drugs
09/22/2005US20050209157 Cause stimulation and proliferation of human fibroblasts and lymphocytes; antibacterial, antifungal, anticancer; containing phenylalanine, leucine, alanine, and lysine amino acid residues
09/22/2005US20050209156 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
09/22/2005US20050209155 IGF-binding protein-derived peptide or small molecule
09/22/2005US20050209154 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease
09/22/2005US20050209153 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
09/22/2005US20050209152 Polypeptoid pulmonary surfactants
09/22/2005US20050209147 Containing a transport domain, a linker and a RhoA domain; antiinflammatory agents in the inhibition of leukocyte adhesion and migration, antiarthritic, antiproliferative, antimetastasis, and antifibrotic agents
09/22/2005US20050209145 Self-assembling peptide amphiphiles and related methods for growth factor delivery
09/22/2005US20050209143 Protein from horn fly saliva that disrupts hemostasis
09/22/2005US20050209140 Methods of controlling axonal growth
09/22/2005US20050209137 Assaying sample for the binding of leptin to an avian leptin receptor binding domain bound to a solid phase (microtitre well plate) and detecting the bound leptin by using a labeled (radiolabeled, chemiluminescent, electroluminescent, fluorescent, enzyme-labeled, or bioluminescent) anti-leptin antibody.
09/22/2005US20050209136 Method for stimulating connective tissue growth or wound healing
09/22/2005US20050209133 Glycoprotein synthesis
09/22/2005US20050209104 Dinoflagellate karlotoxins, methods of isolation and uses thereof
09/22/2005US20050208678 Using capillary electrophoresis and laser induced fluorescent detection to monitor protein complex formation between membrane glycoproteins and helical polypeptides
09/22/2005US20050208662 Enterobacteriaceae fermentation strains
09/22/2005US20050208659 Using adenoviral transformation/transfection to transfer cyclin and cyclin dependent kinase genes into nucleus of differentiated cells; regenerative medicine and tissue engineering
09/22/2005US20050208657 Delivery of functional protein sequences by translocating polypeptides
09/22/2005US20050208652 Isogenic beta-catenin cell lines, and methods of making and using same
1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 2916